Table 1

Demographics of infants and frequency of retinopathy of prematurity (ROP) in the study

Without ROP
frequency (%)
(N=733)
With ROP
frequency (%)
(N=118)
Total
frequency (%)
(N=851)
P value
Year of birth<0.001*
 201313 (1.77)13 (11.02)26 (3.06)
 201495 (12.96)30 (25.42)125 (14.69)
 201579 (10.78)17 (14.41)96 (11.28)
 2016286 (39.02)32 (27.12)318 (37.37)
 2017218 (29.74)21 (17.80)239 (28.08)
 201842 (5.73)5 (4.24)47 (5.52)
Age (Mean±SD)0.006*
 <35 weeks GA647 (88.27)114 (96.61)761 (89.42)
 ≥35 weeks GA86 (11.73)4 (3.39)90 (10.58)
Age, corrected0.367
 <35 weeks GA248 (33.88)35 (29.66)283 (33.29)
 ≥35 weeks GA484 (66.12)83 (70.34)567 (66.71)
Sex0.122
 Female348 (47.48)47 (39.83)395 (46.42)
 Male385 (52.52)71 (60.17)456 (53.58)
Weight (Mean±SD)<0.001*
 <2000 grams612 (83.49)114 (96.61)726 (85.31)
 ≥2000 grams121 (16.51)4 (3.29)125 (14.69)
Initial plan<0.001*
 Observation605 (0.82)51 (43.22)656 (77.09)
 Refer to pedia ophtha127 (0.82)1 (0.85)128 (15.04)
 Surgery08 (6.78)8 (0.94)
 LIO035 (29.66)35 (4.11)
 Advised prognosis07 (5.93)7 (0.82)
 Anti-VEGF02 (1.69)2 (0.24)
 LIO+Anti-VEGF1 (0.14)14 (11.86)15 (1.76)
  • *P value <0.05 considered statistically significant.

  • anti-VEGF, antivascular endothelial growth factor; GA, gestational age; LIO, laser via indirect ophthalmoscopy.